2021 Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria: a multicenter real-life study Group Severe Aplastic Anaemia Working Party (SAAWP) 1st listed author Pierre-Edouard Debureaux Journal Bone Marrow Transplant.
2021 Association study of candidate DNA-repair gene variants and acute graft versus host disease in pediatric patients receiving allogeneic hematopoietic stem-cell transplantation Group Paediatric Diseases Working Party (PDWP) 1st listed author C R S Uppugunduri Journal Pharmacogenomics J.
2021 GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation Group Paediatric Diseases Working Party (PDWP) 1st listed author Simona Jurkovic Mlakar Journal J Cancer Res Clin Oncol.
2021 Recommendations on hematopoietic stem cell transplantation for patients with Diamond-Blackfan anemia. On behalf of the Pediatric Diseases and Severe Aplastic Anemia Working Parties of the EBMT Group Severe Aplastic Anaemia Working Party (SAAWP) Paediatric Diseases Working Party (PDWP) 1st listed author Cristina Diaz-de-Heredia Journal Bone Marrow Transplant.
2021 Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study Group Transplant Complications Working Party (TCWP) 1st listed author D M Greenfield Journal Bone Marrow Transplant.
2021 Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study Group Transplant Complications Working Party (TCWP) 1st listed author Hildegard T Greinix Journal Haematologica.
2021 Correction to: Special issues related to the diagnosis and management of acquired aplastic anemia in countries with restricted resources, a report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP of EBMT) Group Severe Aplastic Anaemia Working Party (SAAWP) 1st listed author Raheel Iftikhar Journal Bone Marrow Transplant.
2021 Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Tomasz Czerw Journal Bone Marrow Transplant.
2021 Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation Group Chronic Malignancies Working Party (CMWP) 1st listed author Firoozeh Sahebi Journal Transplant Cell Ther.
2021 Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Avichai Shimoni Journal Br J Haematol.
2021 Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry Group Chronic Malignancies Working Party (CMWP) 1st listed author Juan-Carlos Hernández-Boluda Journal Am J Hematol.
2021 Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis Group Chronic Malignancies Working Party (CMWP) 1st listed author D McLornan Journal Bone Marrow Transplant.